The replicase of mouse hepatitis virus strain JHM (MHV-JHM) is encoded by two overlapping open reading frames, ORF1a and ORF1b, which are translated to produce a 750-kDa precursor polyprotein. The polyprotein is proposed to be processed by viral proteinases to generate the functional replicase complex. To date, only the MHV-JHM amino-terminal proteins p28 and p72, which is processed to p65, have been identified. To further elucidate the biogenesis of the MHV-JHM replicase, we cloned and expressed five regions of ORF1a in bacteria and prepared rabbit antisera to each region. Using the immune sera to immunoprecipitate radiolabeled proteins from MHV-JHM infected cells, we determined that the MHV-JHM ORF1a is initially processed to generate p28, p72, p250, and p150. Pulse±chase analysis revealed that these intermediates are further processed to generate p65, p210, p40, p27, the MHV 3C-like proteinase, and p15. A putative replicase complex consisting of p250, p210, p40, p150, and a large protein (Ͼ300 kDa) coprecipitate from infected cells disrupted with NP-40, indicating that these proteins are closely associated even after initial proteolytic processing. Immunofluorescence studies revealed punctate labeling of ORF1a proteins in the perinuclear region of infected cells, consistent with a membrane-association of the replicase complex. Furthermore, in vitro transcription/translation studies of the MHV-JHM 3Cpro and flanking hydrophobic domains confirm that 3C protease activity is significantly enhanced in the presence of canine microsomal membranes. Overall, our results demonstrate that the MHV-JHM ORF1a polyprotein: (1) is processed into more than 10 protein intermediates and products, (2) requires membranes for efficient biogenesis, and (3) is detected in discrete membranous regions in the cytoplasm of infected cells.
INTRODUCTION
Mouse hepatitis virus strain JHM (MHV-JHM) is a member of the positive strand RNA virus family Coronaviridae, in the new order Nidovirales (Cavanagh, 1997; de Vries et al., 1997) . Nido, Latin for`ǹest,'' was chosen for this order since the two virus families in the order, the Coronaviridae and Arteriviridae, synthesize a 3Ј-nested set of mRNAs. Furthermore, the nested set of mRNAs is generated by an unusual discontinuous transcription process in which a short leader RNA sequence and the body sequence of the mRNA are joined (Baric et al., 1983; Lai et al., 1994; Spaan et al., 1983; van der Most and Spaan, 1995) . The mechanism by which this discontinuous transcription occurs to generate the nested set of mRNAs is controversial (Jeong and Makino, 1994; Sawicki and Sawicki, 1990; Sethna et al., 1989 ; van Marle et al., 1995; Zhang and Lai, 1995) . However, it is clear that the enzyme that mediates discontinuous transcription is the viral RNA-dependent RNA polymerase, or replicase. By understanding how this replicase is generated and functions throughout the infection cycle, we may gain insight regarding how it mediates the unusual mechanism of discontinuous RNA synthesis.
The MHV-JHM replicase is encoded at the 5Ј-end of the positive strand RNA genome in a region designated gene 1. Gene 1 encompasses 21.7 kb of the almost 32-kb viral genome and contains two overlapping open reading frames: ORF1a (13.6 kb) and ORF1b (8.1 kb) (Lee et al., 1991; Pachuk et al., 1989) . These two open reading frames are joined by a Ϫ1 ribosomal frameshift that occurs during translation of gene 1, leading to the generation of a 750-kDa replicase polyprotein (Brierley et al., 1987; Lee et al., 1991) . This large polyprotein is thought to be processed by viral proteinases to generate the mature, functional replicase complex.
Within gene 1 of MHV there are three predicted proteinase domains, two of which are papain-like cysteine proteinase domains (PCP-1 and PCP-2) and a third which is poliovirus 3C-like (3Cpro) (Gorbalenya et al., 1989; Lee et al., 1991) . To date, only PCP-1 and 3Cpro of MHV have been demonstrated to have activity (Baker et al., 1989 (Baker et al., , 1993 Bonilla et al., 1997; Lu et al., 1995) . The first protein to be processed from the replicase polyprotein, p28, is cleaved from the amino-terminus of the ORF1a polyprotein precursor by the PCP-1 proteinase (Baker et al., 1989; Denison and Perlman, 1987) . This is followed by processing of the adjacent 72-kDa protein and its cleav-age to a 65-kDa protein in MHV-JHM (Gao et al., 1996) . For MHV-A59, p65 has been detected, followed by a 290-kDa protein which is processed into p240 and p50 (Denison et al., 1992 . Two proteins of 27 and 29 kDa, representing the 3Cpro, have also been detected from MHV-A59-infected cells, but no precursor to this protein was detected (Lu et al., 1996; Pin Äo Â n et al., 1997) .
To determine the biogenesis of the MHV-JHM replicase, we sought to identify ORF1a precursors and products from virus-infected cells. Elucidation of the steps in the biogenesis of the coronavirus polymerase from its polyprotein precursor to its functional subunits will aid our understanding of coronavirus transcription, replication, and RNA recombination and may provide valuable insight into targets for anti-viral drug design.
For this study, we prepared rabbit antisera against five regions within MHV-JHM ORF1a and determined that at least 10 intermediates and products are generated by proteolytic processing of the precursor replicase polyprotein. Using pulse±chase analyses, we determined precursor±product relationships between several of these proteins. In addition, we provide immunofluorescence and in vitro processing data to support the hypothesis that the MHV-JHM replicase is a cytoplasmic, membrane-associated enzyme complex.
RESULTS

Identification of MHV-JHM polymerase gene products
To elucidate the biogenesis of the coronavirus RNAdependent RNA polymerase, we generated polyclonal antisera against five regions of MHV-JHM ORF1a. To prepare each antigen of interest, domains within gene 1 were RT-PCR amplified from total RNA of MHV-JHM- 
Underlined nucleotides refer to sequences added for cloning purposes. b Nucleotides numbered according to Lee et al. (1991) as modified by Bonilla et al. (1994) . c Nucleotides in bold indicate base mismatches incorporated into the primer sequence which result in a change in the coding sequence from cysteine to arginine. This amplified product was ligated into the BamHI±EcoRI site of pET-3Cpro as described under Materials and Methods. Lee et al. (1991) as modified by Bonilla et al. (1994) . c p40 detected using lysis method B with ␣D3, ␣D5, and ␣D10 antisera (see Fig. 4 ).
infected cells (see Tables 1 and 2) , cloned in frame with glutathione S-transferase (GST) in the bacterial expression vector pGEX-KG, and expressed as described under Materials and Methods. Affinity-column-purified GST-fusion proteins were used for rabbit immunizations, and sera were collected 10±14 days following each injection. Antibody titer was determined by ELISA assay to GST antigen alone and GST-ORF1a fusion proteins. Final bleed antisera had titers greater than 80,000 against GST-ORF1a fusion proteins.
To identify MHV-JHM ORF1a products, immunoprecipitations from MHV-JHM-infected DBT cell lysates were performed using the D3, D5, and D10 antisera. The fusion proteins used to generate these antisera cover amino acids 784±1037, 1212±1365 and 2820±3060, respectively (Table 2) . Immunoprecipitations with these antisera led to the identification of two high-molecularweight proteins with apparent migrations of 250 and 210 kDa (Figs. 1 A±1C, lane 4) . Longer exposure of the anti-D3 immunoprecipitation revealed proteins of 72 and 65 kDa (Fig. 1A , lane 4), confirming our earlier report of these products (Gao et al., 1996) . In addition, we noted proteins with apparent migrations of 180 and 50 kDa which are nonspecifically recognized by all preimmune and immune sera from infected cell lysates. These bands likely reflect some nonspecific immunoprecipitation of the highly abundant spike (180 kDa) and nucleocapsid (50 kDa) proteins produced during viral replication, as has been previously reported (Denison et al., 1992 . Taken together, the immunoprecipitation results suggest that p250 and p210 may be co-amino terminal (as both are precipitated by anti-D3, which extends only 14.2 kDa into the predicted p250 region), and both proteins extend to at least aa 2820 (as both are precipitated by anti-D10).
To study the synthesis and processing of p250 and p210 in vivo, pulse±chase analyses were performed (Figs. 1D±1F). MHV-JHM infected cells were pulsed with [ 35 S]methionine for 30 min, washed with PBS, chased with unlabeled media, and lysed as described under Materials and Methods. Immunoprecipitation of these lysates with anti-D3, anti-D5, and anti-D10 sera revealed a gradual decline in the intensity of p250 and concomitant increase in the intensity of p210, suggesting that p250 and p210 have a precursor±product relationship. We also expected to find a protein of approximately 40 kDa which would represent the remaining cleavage product of p250. However, we have been unable to detect p40 using this method. Therefore, we cannot yet definitively conclude whether p210 is co-amino-or cocarboxy-terminal with p250. Amino-terminal sequencing of p250 and p210 will be required to determine if they are truly co-amino-terminal, and at which precise amino acid they begin. To date, we have been unable to purify sufficient quantities of these proteins for amino-terminal sequencing studies.
The detection of some unprocessed p250 even 120 min into the chase (Figs. 1D±1F, lane 6) suggests that the cleavage of p250 to p210 likely occurs slowly and posttranslationally. This is in contrast to the rapid cleavage of the amino-terminal product of the polymerase polyprotein, p28, which likely occurs cotranslationally and in cis (Denison and Perlman, 1987; Gao et al., 1996) , although it has been recently shown that the cleavage can also be mediated in trans in vitro using an internal deletion construct of the 5Ј end of the MHV-A59 ORF1a . The differences in the rates of processing may have important implications on replicase assembly and function (see Discussion).
Comparison of MHV-JHM and MHV-A59 ORF1a gene products
Two high molecular mass proteins, p290 and p240, have previously been reported as ORF1a cleavage products of MHV-A59 (Denison et al., 1992 . To determine if the MHV-JHM ORF1a processing is distinct from MHV-A59, we analyzed radiolabeled A59 and JHM lysates by immunoprecipitation with anti-D3 serum and SDS±PAGE ( Fig. 2A ). As seen in lanes 5 and 6, the high molecular mass proteins from both virus strains migrate identically under denaturing conditions in a 5±15% gradient SDS±polyacrylamide gel. According to our molecular mass determinations (see Materials and Methods), these proteins migrate with apparent masses of 250 and 210 kDa. Furthermore, these molecular mass estimates are consistent with the expected molecular mass calculated for the region bounded by p72 and the downstream protein p150 described below (see Fig. 7 and Table 3 ). Interestingly, the p72 protein appears to be unique to the MHV-JHM strain. Alignment of amino acids surrounding the p65 and p72 cleavage sites indicates that the p65 cleavage ]methionine from 6.0 to 7.5 h p.i. and lysed in buffer A, as described under Materials and Methods. Viral proteins were immunoprecipitated from lysates of mock-infected (lanes 1 and 3) and JHM-infected (lanes 2 and 4) cells using preimmune sera (lanes 1 and 2) and the indicated immune sera (lanes 3 and 4). Proteins p250, p210, p72, and p65 found only in infected cell lysates with immune sera are indicated by arrows. (D, E, and F) Pulse±chase analyses indicating precursor±product relationships between proteins. Mock-infected and JHMinfected cells were labeled with [ 35 S]methionine from 6.0 to 6.5 h p.i., washed with normal media, and then chased for the indicated periods of time in media containing excess cold methionine before lysis in buffer A and immunoprecipitation as described above. U, uninfected cell lysates; I, infected cell lysates. All samples were analyzed by electrophoresis in 5±15% gradient SDS±PAGE gels and visualized by fluorography. Molecular mass markers are labeled in kilodaltons on the left of each gel. Exposure lengths are indicated below each gel. site is identical in the two strains, whereas there is one potentially significant difference at the P1 position of the predicted p72 cleavage site (a Gly to Asp substitution; see Fig. 2B ). This substitution may prevent recognition of this cleavage site in the A59 ORF1a polyprotein and therefore explain the absence of the p72 product in A59-infected cells.
Identification of MHV-JHM 3Cpro and its precursor polyprotein
All coronavirus genomes studied to date encode a poliovirus 3C-like proteinase domain (3Cpro) (Bonilla et al., 1994; Boursnell et al., 1987; Eleouet et al., 1995; Gorbalenya et al., 1989; Herold et al., 1993; Lee et al., 1991) . For MHV- a Amino acids numbered according to Lee et al. (1991) as modified by Bonilla et al. (1994) . b p28 cleavage site as determined by Dong and Baker (1994) and Hughes et al. (1995) . c p65 cleavage site as determined by Bonilla et al. (1997) . d Protein product predicted but not observed. e p27 amino-terminal cleavage site as determined by Lu and Denison (1997) . f The predicted uncleaved product is not observed because it is cleaved cotranslationally. A59, this domain spans amino acids 3334±3636 (corresponding to amino acids 3337±3639 of MHV-JHM). For the coronaviruses MHV-A59, avian infectious bronchitis virus (IBV) and human coronavirus (HCV-229E), this domain has been shown to have protease activity when translated in vitro, purified from virus-infected cells, or expressed in bacteria and purified (Lu et al., 1995 (Lu et al., , 1996 Seybert et al., 1997; Tibbles et al., 1996; Ziebuhr et al., 1995) . The catalytic cysteine and histidine residues of the MHV-A59 and IBV proteases have been identified (Liu and Brown, 1995; Lu and Denison, 1997; Lu et al., 1995) , and the 3Cpro domain was detected by immunoprecipitation from MHV-A59-infected cell lysates in two different reports as a 27-or 29-kDa protein (Lu et al., 1996; Pin Äo Ân et al., 1997) . To identify the MHV-JHM 3Cpro, we prepared the fusion protein antiserum D12. The D12 domain is located within the 3C protease, specifically covering the catalytic histidine residue but not the cysteine residue (amino acids 3340±3470).
Immunoprecipitation with anti-D12 serum from MHV-JHM-infected cell lysates identified proteins of 27 and 150 kDa on 5±15% gradient SDS±PAGE gels (Fig. 3A , lane 4). Pulse±chase analysis with anti-D12 serum suggests a precursor and product relationship between p150 and p27, as reflected by the appearance of p27 30 min into the chase, and the concomitant decrease in intensity of p150 ( Fig. 3C ). This result is consistent with proteolytic cleavages mediated by 3Cpro occurring at Gln/Ser cleavage sites upstream and downstream of the 3Cpro catalytic center, as has been reported for MHV-A59 (Lu et al., 1996) . The detection of p150 is the first report of a precursor to 3Cpro. We propose that the p150 extends from a putative cleavage site upstream of the hydrophobic domain termed MP1 (Gorbalenya et al., 1989; Lee et al., 1991) to the end of ORF1a (Val 4474). The predicted molecular weight for this region is 150.5 kDa, similar to the apparent molecular weight of 150 kDa on SDS±PAGE gels (Table 3) .
Immunoprecipitations of JHM-infected cell lysates with antiserum D15, directed against amino acids 4200±4461 near the carboxy-terminal region of ORF1a further support this hypothesis. The D15 antiserum immunoprecipitates a 150-kDa protein that decays with kinetics identical to those seen in the anti-D12 pulse±chase (Figs. 3B and 3D). To detect lower-molecular-weight cleavage products of p150, we analyzed the products by 15% SDS±PAGE (Fig. 3E ). After prolonged exposure, we detected a product of 15 kDa which accumulates during the chase period. The p15 likely represents the carboxy-terminal or penultimate cleavage product of MHV-JHM ORF1a.
Effect of lysis conditions on detection of MHV-JHM ORF1a gene products
While working to optimize the conditions for immunoprecipitation of MHV-JHM ORF1a gene products, we found that the conditions used to prepare the cell lysates were critical for the detection of all MHV-JHM ORF1a products. We routinely use highly denatured total cell lysates (prepared using lysis buffer A as described under Materials and Methods) for immunoprecipitations. As shown above ( Fig. 1) , these conditions facilitate specific detection of MHV-JHM ORF1a gene products. Interestingly, when cell lysates were prepared using NP-40 lysis followed by isolation of postnuclear supernatants (lysis buffer B, see Materials and Methods), we detected coprecipitation of viral proteins, indicating that these proteins likely reside in the cell as a complex. Under these conditions, all five antisera described above precipitate viral proteins of Ͼ300 kDa, p250, p210, and p150 ( Fig. 4) . A protein of approximately 40 kDa is also detected using the anti-D3, anti-D5, and anti-D10 sera. In pulse±chase analyses of NP-40 lysates with these same three antisera, p40 is seen to accumulate during the chase concomitant with the increase in p210 and decrease in p250 intensities (data not shown). This viral p40 likely represents the additional cleavage product generated when p250 is cleaved to generate p210. Since neither the anti-D3 nor anti-D10 serum specifically immunoprecipitates this product, it is unclear if p40 represents the amino-or carboxy-terminal cleavage product of p250. The large (Ͼ300 kDa) protein likely represents an ORF1a/ORF1b polyprotein generated by ribosomal frameshifting during translation. In addition to the highmolecular-weight proteins, some specific products are also detected: p65 using anti-D3 (Fig. 4, lane 2) , p27 using anti-D12 (lane 8), and p15 using anti-D15 (lane 10). The specific precipitation of the lower molecular-weight proteins demonstrates the specificity of the antisera. The coprecipitation of the high molecular weight proteins under these conditions is consistent with the hypothesis that the MHV polymerase exists as a complex of ORF1a/ ORF1b cleavage products in vivo.
Detection of MHV-JHM ORF1a proteins by immunofluorescence
To determine the intracellular localization of MHV-JHM ORF1a proteins, immunofluorescence studies were performed. DBT cells were infected with MHV-JHM, fixed with formaldehyde at 5.5±6.0 h after infection, and incubated with specific antisera as described under Materials and Methods. MHV ORF1a products were detected using anti-D3 and anti-D12 antisera (Fig. 5 ). Both antisera revealed a similar, and somewhat polar, punctate staining pattern in the perinuclear region of infected cells. This pattern is consistent with MHV replicase association with discrete vesicular structures in the cells. Although not all gene 1 cleavage products are predicted to contain hydrophobic domains, it is possible that strong protein±protein interactions hold the subunits together in a membrane-associated complex. The MHV ORF1a localization we see is similar to the pattern of localization reported for ORF1b proteins in equine arteritis virus (EAV)-infected cells (van Dinten et al., 1996) . Further studies will be required to determine the precise subcellular localization site of the MHV replicase complex.
Effect of membranes on MHV-JHM 3Cpro activity
In the case of the IBV 3C-like proteinase, canine microsomal membranes (CMMs) have been shown to be Immunoprecipitations and pulse±chase analyses were performed as described in the legend to Fig. 1 , using anti-D12 (A and C) and anti-D15 (B, D, and E) antisera. Samples were analyzed by electrophoresis in 5±15% gradient SDS±PAGE (A±D) or 15% (E) gels and visualized by fluorography. U, uninfected cell lysates; I, infected cell lysates; pre, immunoprecipitations using preimmune sera; remaining lanes immunoprecipitated with the indicated immune sera. Proteins p150, p27 (3Cpro), and p15 are indicated by the arrows. Molecular mass markers are indicated on the left, and exposure lengths are indicated below each gel. necessary for in vitro 3Cpro protease activity (Tibbles et al., 1996) . However, for MHV-A59 it has been demonstrated that 3Cpro (p27) does not strictly require membranes for in vitro trans-cleavage activity (Lu et al., 1996) , but that it does require membranes for efficient activity if major portions of the flanking hydrophobic domains are present in the expression constructs (Pin Äo Â n et al., 1997) . To investigate the activity of the MHV-JHM 3Cpro, the predicted protease domain along with the full-length flanking hydrophobic domains (MP1 and MP2, membrane proteins 1 and 2) were cloned into the in vitro expression vector pET-11d under T7 promoter control and tested for protease activity in the presence and absence of membranes. A mutant 3Cpro construct was generated by polymerase chain reaction (PCR) mutagenesis, resulting in a substitution of the catalytic cysteine residue with an arginine residue (Table 1) . Both wild type and mutant 3Cpro constructs were cotranscribed/translated in vitro with [ 35 S]methionine in the absence and presence of CMMs, and equal TCA-precipitable counts of each reaction were analyzed by SDS±PAGE and autoradiography (Fig. 6 ). Comparison of lanes 1 and 2 from this experiment indicates that the p27 cleavage product (3Cpro) is generated more efficiently from the 91 kDa translation product in the presence of CMMs (Fig. 6, lane  2) . This may be due to an effect of membranes on the conformation of the proteinase itself or to an alteration in accessibility of the cleavage sites. Longer exposures of the gel in Fig. 6 show small quantities of p27 generated in the absence of membranes, in lane 1 (data not shown). As expected, pET-mut3Cpro does not generate p27 in the absence or presence of membranes (lanes 3 and 4) . These results are consistent with the observations of Pin Äo Â n et al. (1997) in that 3C processing events specifically leading to the release of p27 in vitro can occur in the absence of exogenously added membranes, but that they are greatly enhanced in the presence of CMMs. Finally, these data support the hypothesis that 3Cpro likely needs to be associated with intracellular membranes for efficient activity during virus infection.
DISCUSSION
Here we report the identification of six MHV-JHM gene 1 products, p250, p210, p40, p150, p27, and p15, which, together with the previously described products p28, p72, and p65, span the entire 4474 amino acids encoded by ORF1a (Table 3) . Based on apparent molecular masses of proteins identified by immunoprecipitation using antisera generated to ORF1a fusion proteins, as well as the known location of each fusion protein epitope, we deduced that the ORF1a polyprotein is initially cleaved to generate four products, p28, p72, p250, and p150 (Fig. 7) . P28, the amino-terminal cleavage product, is rapidly cleaved and is stable for at least 90 min after processing (Baker et al., 1989; Denison and Perlman, 1986; Gao et al., 1996) . P72, p250, and p150 represent intermediates in the proteolytic processing of ORF1a. P72 is processed to p65 (Gao et al., 1996, and Fig . 1D ). P250 is processed to p210 and p40, with p40 likely representing the carboxy-terminal cleavage product of p250 ( Figs. 1 and 4) . P150, which represents the carboxy-terminal region of ORF1a, is processed to p27, the MHV-JHM 3C-like proteinase, and p15 (Fig. 3) . P150 is likely processed into several additional products as well.
Direct comparisons of MHV-JHM and A59 ORF1a gene products identified to date suggest that there may be one or more processing events unique to each strain. To determine if the high molecular mass JHM ORF1a products p250 and p210 identified here are distinct from previously described high molecular mass A59 products p290 and p240 (Denison et al., 1992 , we directly compared anti-D3 immunoprecipitations from radiolabeled JHM and A59 lysates (Fig. 2) . Identical rates of migration by SDS±PAGE suggest that the two proteins, which under these conditions migrate with apparent molecular masses of 250 and 210 kDa, likely represent comparable regions of ORF1a from both strains. A processing event which is unique is the generation of p72 in the MHV-JHM strain. Immunoprecipitation of JHM and A59 lysates with anti-D3 ( Fig. 2A) and anti-647 sera (H. Q. Gao and S. C. Baker, unpublished observations) demonstrated that the p72 protein is unique to the JHM strain. This is likely due to the presence of a putative PCP-1 cleavage site in the JHM strain that is not conserved in the A59 strain (Fig. 2B) .
We show that the MHV-JHM ORF1a polyprotein is cleaved into at least 10 intermediates and protein prod- FIG. 7. Schematic representation of MHV-JHM ORF1a processing products. The 4474-amino-acid-long ORF1a polyprotein is cleaved to generate a series of intermediates and products depicted here, reflecting results described in this paper. Fusion protein domains used to generate antisera and detect cleavage products are depicted on the amino acid scale at the top. MHV-JHM ORF1a cleavage products are depicted with the observed molecular mass of each protein shown inside each box. Viral proteins labeled 6.0±6.5 h p.i. cleave rapidly to generate p28 and the downstream intermediates p72, p250, and p150. Intermediates are processed at varying rates to generate products p65, p210, p40, p27, and p15, all of which remain stable during a 180-min chase period. The three previously defined cleavage sites at the carboxy-terminus of p28, the carboxy-terminus of p65, and the amino-terminus of 3Cpro (p27) are shown. The G/V and A/G cleavage events are mediated by PCP-1, and the Q/S cleavage is mediated by 3Cpro. The exact amino-and carboxy-termini of all other proteins have not yet been determined, as depicted by the dotted lines. The location of the internal cleavage of p250 which results in the generation of p210 and p40 has not been definitively determined. Question marks indicate putative products that remain to be identified. ucts, and clearly more products await identification. The proteolytic pathway used to generate these protein products is being actively investigated. To date, we know that the first papain-like cysteine proteinase (PCP-1) cleaves at G/V and A/G sites to generate p28 and p65, respectively Dong and Baker, 1994; Hughes et al., 1995) . Based on the size estimates of the cleavage products identified here and an analysis of potential cleavage sites, we speculate that PCP-1 (or potentially the PCP-2 domain located downstream of PCP-1) is responsible for cleavage of p72 and p250. Putative cleavage sites and size estimates of the resulting protein products are listed in Table 3 . The relative positions of p210 and p40 are currently unclear since neither anti-D3 nor anti-D10 serum specifically immunoprecipitates p40. Because the D3 antigen encompasses only the amino terminal 14.2 kDa of p250 and the anti-D3 antiserum detects both p250 and p210, it is likely that p250 and p210 are co-amino-terminal. However, if p250 and p210 are co-amino-terminal, the D10 antiserum should encompass regions of both p210 and p40. It is currently unclear why we are unable to specifically precipitate p40 with any antiserum.
The proteolytic processing of the Nidovirus polymerases appears to be quite complex, requiring multiple proteinases and generating multiple intermediates. For the best studied Nidovirus, EAV, the 1727-aa (187-kDa) ORF1a polyprotein is cleaved into at least eight protein products (nsp1±8) by three distinct viral proteinases. Furthermore, alternative (and likely mutually exclusive) major and minor processing pathways for the EAV ORF1a polyprotein have been proposed (Wassenaar et al., 1997) . In addition, provisional mapping of the EAV ORF1b polyprotein suggests that there are at least four ultimate ORF1b cleavage products. However, since proteolytic processing of the EAV ORF1b polyprotein occurs quite slowly, a number of intermediates are also present in EAV-infected cells (van Dinten et al., 1996) . These findings illustrate the complexity of Nidovirus replicase complexes.
It is likely that some of the intermediates generated during processing of the MHV gene 1 polyprotein mediate functions distinct from those of the final processed products. The cleavage of p250 to p210 and p40 occurs relatively slowly in infected cells, with p250 still detectable 120 min after pulse labeling (Fig. 1) . It is possible that MHV replicase complexes consisting of differentially processed ORF1a products are present in infected cells and exert distinct functions on viral RNA synthesis. In the Sindbis virus system it has been shown that replication of the viral RNA to negative sense and back to positive sense transcripts is regulated by differential processing of a nonstructural protein precursor P123 (de Groot et al., 1990; Lemm and Rice, 1993; Shirako and Strauss, 1994) . Early after Sindbis virus infection, P123 together with nsP4 forms the negative strand replication complex. In contrast, late in infection after the viral nsP2 proteinase has accumulated to significant levels, fully processed nsP1, nsP2, nsP3, and nsP4 form the positive strand replication complex and shift viral RNA synthesis from the production of negative strand templates to the production of genome-sense transcripts. Similar to Sindbis virus, the coronavirus replicase contains numerous cleavage sites and several proteinase domains responsible for processing the large replicase polyprotein. Accumulation of the viral PCP-1 and 3Cpro proteinases during the course of infection very likely alters the kinetics of trans-cleavage events and the stability of the p72, p250, and p150 processing intermediates which may play distinct regulatory roles in coronavirus genome replication.
Membrane association of many positive-strand RNA virus replication complexes has been described in the literature (Bienz et al., 1994; Chambers et al., 1990; Froshauer et al., 1988; van Dinten et al., 1996) . Due to the presence of predicted hydrophobic stretches within the MHV gene 1 polyprotein (Gorbalenya et al., 1989; Lee et al., 1991) , it is thought that some of the mature gene 1 products may be transmembrane proteins which serve to anchor the viral replicase complex to membranes via protein±protein interactions. In this report, we demonstrate that the MHV-JHM ORF1a proteolytic products are present as a complex in virus-infected cells. When infected cells are disrupted by mild detergent (0.5% NP-40), protein complexes are precipitated with ORF1a antisera (Fig. 4) . These complexes consist of: a high-molecularweight protein (Ͼ300 kDa) which we speculate extends from ORF1a into ORF1b by ribosomal frameshifting during translation; p250, p210, and p40 which represent the central domain of ORF1a and include the two papain-like cysteine proteinases, PCP-1 and PCP-2; and p150, which represents the carboxy-terminal portion of ORF1a and includes the 3C-like proteinase. Intracellular immunofluorescence analysis revealed that this complex localizes to the perinuclear region, likely the endoplasmic reticulum or intermediate compartment (Fig. 5 ). Replicase complex formation and ER localization has also been reported for the EAV replicase (Snijder et al., 1994; van Dinten et al., 1996) . Similarly, one MHV-A59 ORF1a product has been localized to the Golgi apparatus by immunofluorescent staining (Bi et al., 1995) . It is interesting to note that although EAV ORF1b products localize to membranes, the only hydrophobic, potentially membranespanning regions of gene 1 are found within ORF1a surrounding the viral 3C-like nsp4 protease domain (Snijder et al., 1994) . Additionally, EAV ORF1a proteins have been shown to coimmunoprecipitate with ORF1bspecific antisera (van Dinten et al., 1996) , suggesting strong protein±protein interactions between the cleaved gene 1 products in vivo.
For the MHV replicase, the two regions flanking the 3Cpro, termed MP1 and MP2, are likely transmembrane domains which may direct the precursor polyprotein to intracellular membranes. For MHV-A59 it has been shown that the hydrophobic domains flanking 3Cpro associate with membrane fractions of in vitro translation reactions (Pin Äo Â n et al., 1997) . Even after proteolytic processing, these transmembrane domains may anchor 3Cpro and other ORF1a/ORF1b proteins to membranes by strong protein±protein interactions. The results of Pin Äo Â n et al. (1997) demonstrated that addition of membranes to an in vitro transcription/translation reaction significantly increased the efficiency of 3Cpro cleavage from flanking hydrophobic regions. Similarly, we found that addition of canine microsomal membranes to in vitro transcription/translation reactions of an MHV-JHM 3Cpro precursor dramatically enhanced the efficiency of the processing events, generating a p27 (3Cpro catalytic core; Fig. 6 ). These results are consistent with the hypothesis that membrane association of 3Cpro in vivo is probably necessary for it to adopt a proteolytically efficient conformation and that the regions surrounding this domain are responsible for mediating its membrane association.
Taken together, these data imply that Nidovirus gene 1 cleavage products assemble into a large replication complex that is anchored to membranes by protein± protein interactions with the hydrophobic ORF1a product(s). Future studies are aimed at determining if altered proteolytic processing or assembly of the replicase complex affects viral RNA synthesis.
MATERIALS AND METHODS
Virus and cells
Plaque-cloned MHV strains JHM (Makino et al., 1984) and A59 (Lai and Stohlman, 1981) were used throughout this study. Gene 1 of both strains has been completely cloned and sequenced (Lee et al., 1991 , as modified by Bonilla et al., 1994 Bredenbeek et al., 1990, and Bonilla et al., 1994, for MHV-A59) . The viruses were propagated on DBT cells (Hirano et al., 1974) maintained in Dulbecco's modified eagle medium supplemented with 5% fetal calf serum (FCS), 10% tryptone phosphate broth, 2% penicillin/streptomycin, and 2% L-glutamine (all tissue culture reagents were from Gibco-BRL, Gaithersberg, MD).
Generation of rabbit antisera to MHV-JHM ORF1a regions
A panel of antisera directed against specific domains of MHV-JHM ORF1a was generated using the overall strategy of reverse transcription and polymerase chain reaction (RT-PCR) amplification of a region of interest, cloning and expression of the region as a GST-fusion protein, purification of the GST-ORF1a fusion protein, and injection of the purified fusion protein into rabbits. Briefly, DBT cells were infected with MHV-JHM at a multiplicity of infection (m.o.i.) of 5. RNA was isolated from the cells at 12±13 h postinfection (p.i.) using RNAzol B according to manufacturer's instructions (Tel-test, Inc., Friendswood, TX) . cDNA was generated by first denaturing 0.1 g RNA with 18 mM methyl mercury hydroxide for 5 min at room temperature. The RNA was then incubated for 2 h at 42°C in a reaction mixture containing the following: 0.07 M ␤-mercaptoethanol, 0.1 g random hexamer oligonucleotide primers, 10 M each deoxyribonucleoside triphosphate, 85 mM Tris±HCl, pH 8.3, 34 mM KCl, 8.5 mM MgCl 2 , 40 U of RNAsin and 8 U of avian myeloblastosis virus reverse transcriptase (Seikagaku America, Inc., Rockville, MD). The cDNA synthesis reaction was terminated by heat inactivation at 95°C for 3 min, and then quickly cooled on ice.
Regions of interest were amplified from the cDNA using specific primers (Table 1) . Each PCR reaction contained approximately 30 ng of cDNA, 0.4 M each primer, 0.25 mM each dNTP, 1 l Advantage KlenTaq Polymerase Mix, and 10ϫ PCR reaction buffer (Clontech, Palo Alto, CA) in a total reaction volume of 50 l. Amplification conditions consisted of 35 cycles of: 94°C for 2 s, 50°C for 30 s, and 68°C for 1 min. Each PCR product was digested with restriction enzymes and ligated into the XbaI and HindIII sites of the bacterial expression vector pGEX-KG (kindly provided by Dr. Steven Broyles, Indiana University). Following transformation of the ligation reaction into Escherichia coli DH5 alpha cells, ampicillin-resistant bacteria were induced for fusion protein production using the method of Guan and Dixon (1991) . Briefly, bacteria were grown at 30°C in 2ϫ YT containing 50 g/ml ampicillin until cultures reached an OD 600 of 0.5±0.55. Fusion proteins were then induced by the addition of IPTG, as optimized for each transformant: 50 M IPTG for 1 h (D5, D12, and D15), 50 M IPTG for 2 h (D10), or 100 M IPTG for 2 h (D3). Cells were harvested by centrifugation (3000 g). The bacteria from 1 l of culture was resuspended in 100 ml PBS and lysed by sonication. Fusion proteins were isolated from the soluble fraction by affinity chromatography over glutathione± sepharose bead columns as described by the manufacturer (Pharmacia Biotech, Piscataway, NJ). The fusion proteins were eluted by competition with 20 mM glutathione in 120 mM NaCl and 100 mM Tris±HCl, pH 8.0. The yield per liter of culture varied greatly, ranging from 400 g to 7 mg, depending on the apparent solubility of each fusion protein. Approximate yields of purified protein were as follows: D3, 7.0 mg/l; D5, 970 g/l; D10, 800 g/l; D12, 400 g/l, and D15, 2.5 mg/l. Rabbits were injected intramuscularly and subcutaneously with 1 ml of 200±500 g protein emulsified in 1 ml of Freund's adjuvant (complete adjuvant for first injection; incomplete for two or three subsequent in-jections, each approximately 30 days apart). Immune sera were collected 10±14 days following each injection.
Preparation of radiolabeled whole cell lysates
Monolayers of 80±100% confluent DBT cells in 100 mm petri dishes were infected with MHV-JHM at an m.o.i. of 5±10 plaque-forming units/cell for 1 h, and then incubated at 37°C in supplemented media containing 4 g/ml Actinomycin D for an additional 4.5 h. At 5.5 h p.i. media were replaced with MEM lacking methionine for 30 min. Proteins were metabolically radiolabeled with [ 35 S]methionine (100 Ci/ml; ICN, Costa Mesa, CA) for 90 min, unless indicated otherwise in the text. For direct labeling experiments, cells were washed following labeling with cold PBS on ice and lysed in 300 l of either lysis buffer A or B (see below). For pulse±chase experiments, cells in 60-mm dishes were labeled for 30 min, washed twice with supplemented MEM, and incubated with media containing a 10-fold excess of methionine (3 mM) and cysteine (4 mM) for the chase periods. At the times p.i. indicated in the text for each experiment, one plate of cells was washed with cold PBS on ice and lysed in 150 l of lysis buffer A. Lysis buffer A contained 4% SDS, 3% DTT, 40% glycerol, and 0.0625 M Tris, pH 6.8 (as previously described, Baker et al., 1989) . Lysates prepared in buffer A were passed through a 22-gauge needle to shear chromosomal DNA and either used directly or frozen at Ϫ80°C. Lysis buffer B contained 100 mM NaCl, 10 mM Tris±HCl, pH 7.5, 1 mM EDTA, 0.5% NP-40, 0.1 mM PMSF, and 0.3 TIU/ml aprotinin. Lysates prepared in buffer B were solubilized by pipetting, nuclei pelleted by centrifugation for 5 min at 8000 rpm, and the postnuclear supernatants harvested and either used directly or frozen at Ϫ80°C.
Immunoprecipitation of MHV-JHM ORF1a proteins
Virus-encoded polyproteins expressed during infection of DBT cells were identified by immunoprecipitation from whole cell lysates prepared as described above. Lysates from about 1 ϫ 10 6 cells were immunoprecipitated with 5±10 l of antisera in a total volume of 1 ml RIPA buffer (0.5% Triton X-100, 0.1% SDS, 300 mM NaCl, 50 mM Tris±HCl, pH 7.4, 4 mM EDTA). Antibody±antigen complexes were precipitated by addition of 40 l of a 1:1 suspension of protein A±Sepharose CL4B beads (Pharmacia Biotech, Piscataway, NJ) in RIPA buffer. Antibody± antigen complexes were washed one time with 1 ml RIPA buffer, and then incubated 30 min at 37°C or boiled for 3 min in 30 l of Laemmli 2ϫ sample buffer (Laemmli, 1970) . Proteins were electrophoresed on 15% polyacrylamide gels containing 0.1% sodium dodecyl sulfate (SDS±PAGE gels) or 5±15% gradient SDS±PAGE gels, as indicated in the text. Following electrophoresis, gels were fixed in 25% methanol and 10% acetic acid, en-hanced with Entensify A and B (NEN Research Products, Boston, MA), dried, and exposed to Kodak X-ray film at Ϫ80°C.
Molecular mass estimates of MHV-JHM ORF1a products
For molecular mass determinations, immunoprecipitated products were electrophoresed on 5 and 7.5% SDS±PAGE gels along with three standards: See Blue, which contains a 250-kDa protein (Novex, San Diego, CA), Bench Mark, and a 14 C high molecular weight standard (Gibco BRL, Gaithersburg, MD). Estimates of molecular mass of ORF1a products were calculated from regression curves of log molecular weight vs. relative mobility (R f ) established using the standards.
Immunofluorescence detection of MHV-JHM ORF1a proteins
Monolayers of 5.0 ϫ 10 4 DBT cells in eight-well chamber slides were infected with MHV-JHM at an m.o.i. of 10 and incubated at 37°C. At 5.0±5.5 h p.i., the cells were washed two times with PBS and fixed with 3.7% formaldehyde in PBS for 30 min. The fixed cells were washed three times with PBS containing 10 mM glycine, permeabilized with 0.1% Triton X-100 for 10 min, and then washed three times with PBS containing 10 mM glycine. The fixed cells were incubated overnight with 1:2000±1: 3500 dilutions of the designated primary rabbit antisera in PBS, 5% FCS, and 0.3% saponin (ICN, Cleveland, OH) at 4°C in a moist chamber. Following this incubation, cells were washed with PBS and 0.03% saponin for 1 h, and then incubated with FITC-conjugated donkey antirabbit IgG (Jackson ImmunoResearch Laboratories, West Grove, PA) at a dilution of 1:200 in PBS, 5% FCS, 0.3% saponin, and 0.001% DAPI (4,Ј6-diamidino-2-phenylindole; Sigma, St. Louis, MO) at 37°C for 1 h. The cells were then washed with PBS and 0.03% saponin for 1 h and mounted with 50% glycerol and glass coverslips. The cells were examined under a fluorescence microscope (Nikon) and photographed using Fuji (ASA 800) color print film.
In vitro cloning and expression of the MHV-JHM 3Clike proteinase domain
The 3C proteinase domain was RT-PCR amplified as described above using the primers indicated in Table 1 . The forward PCR primer was designed with an ATG start codon in good Kozak consensus sequence (Kozak, 1989) , and the reverse primer was designed with an in-frame stop codon. The PCR product was digested with XbaI and EcoRI and directionally cloned into plasmid pET-11d (Novagen, Madison, WI) under the control of a T7 promoter and lac operator. This plasmid was designated pET-3Cpro. To generate the mutant 3Cpro expression construct, the BamHI±EcoRI fragment of pET-3Cpro was replaced with a fragment generated by PCR using primers B153 and B158 (Table 1) , which encodes an arginine instead of a cysteine at position 3481. The resultant plasmid was designated pET-mut3Cpro. The catalytic regions of pET-3Cpro and pET-mut3Cpro were confirmed by dideoxy sequencing (Sequenase DNA sequencing kit, Version 2.0; U. S. Biochemicals, Cleveland, OH) using primer B169 (5Ј-CATACAATGGCAGACCC-3Ј), which binds nucleotides 10572±10588 of MHV-JHM ORF1a (numbered according to Lee et al., 1991 , as modified by Bonilla et al., 1994 .
Plasmid DNAs were cotranscribed and translated in rabbit reticulocyte lysates (TNT lysates; Promega Biotech, Madison, WI) according to the manufacturer's instructions. Reactions were performed in a total volume of 12.5 l using approximately 1 g of supercoiled plasmid DNA and 10 Ci of [ 35 S]methionine (ICN Biomed., Costa Mesa, CA), and incubated at 30°C for 90 min. [ 35 S]Methionine incorporation into the translation products was quantitated by trichloroacetic acid (TCA) precipitation (Maniatis et al., 1982) . Equal TCA-precipitable counts (50,000 cpm) of each protein product were mixed with Laemmli 2ϫ sample buffer, boiled 3 min, analyzed by gel electrophoresis in 12.5% SDS±PAGE gels, and visualized by fluorography, as described above.
